p53 and little brother p53/47: linking IRES activities with protein functions

被引:0
|
作者
R Grover
M M Candeias
R Fåhraeus
S Das
机构
[1] Indian Institute of Science,Department of Microbiology and Cell Biology
[2] Inserm U716,undefined
[3] Pharmacologie Expérimentale,undefined
[4] Institut Génétique Moléculaire,undefined
[5] Hôpital St Louis and Université Paris 7,undefined
[6] 4Current address: Institute of Bioinformatics and Applied Biotechnology,undefined
[7] Bangalore,undefined
[8] India.,undefined
[9] 5Current address: Department of Clinical Molecular Biology,undefined
[10] Graduate School of Medicine Kyoto University,undefined
[11] Kyoto 606-8507,undefined
[12] Japan.,undefined
来源
Oncogene | 2009年 / 28卷
关键词
p53; p53/47; IRES; translational control;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor p53 represents a paradigm for gene regulation. Its rapid induction in response to DNA damage conditions has been attributed to both increased half-life of p53 protein and also increased translation of p53 mRNA. Recent advances in our understanding of the post-transcriptional regulation of p53 include the discovery of internal ribosome entry sites (IRESs) within the p53 mRNA. These IRES elements regulate the translation of the full length as well as the N-terminally truncated isoform, p53/47. The p53/47 isoform is generated by alternative initiation at an internal AUG codon present within the p53 ORF. The aim of this review is to summarize the role of translational control mechanisms in regulating p53 functions. We discuss here in detail how diverse cellular stress pathways trigger alterations in the cap-dependent and cap-independent translation of p53 mRNA and how changes in the relative expression levels of p53 isoforms result in more differentiated p53 activity.
引用
收藏
页码:2766 / 2772
页数:6
相关论文
共 50 条
  • [41] Twenty years of p53 research: structural and functional aspects of the p53 protein
    Pierre May
    Evelyne May
    Oncogene, 1999, 18 : 7621 - 7636
  • [42] Rearrangement of p53 gene with overexpressed p53 protein in primary cervical cancer
    Sahu, GR
    Nayak, BK
    Patnaik, S
    Parija, T
    Das, BR
    ONCOLOGY REPORTS, 2002, 9 (02) : 433 - 437
  • [43] p53 Protein expression and p53 mutation in thymic epithelial tumors - Reply
    Tateyama, H
    Eimoto, T
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (05) : 658 - 658
  • [44] Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research
    Levine, Arnold J.
    CANCER RESEARCH, 2022, 82 (03) : 362 - 364
  • [45] Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium
    Tsai, YY
    Chang, KC
    Lee, H
    Cheng, YW
    Tsai, FJ
    Tseng, SH
    Ao, HS
    Chau, PS
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (01): : 60 - 62
  • [46] P53 FUSION PROTEIN EXPRESSION IN PROKARYOTE AND PREPARATION OF MONOCLONAL ANTIBODY TO P53
    刘彩云
    寿成超
    孙素莲
    张蕾
    曾荔
    ChineseJournalofCancerResearch, 1998, (02) : 28 - 31
  • [47] Twenty years of p53 research: structural and functional aspects of the p53 protein
    May, P
    May, E
    ONCOGENE, 1999, 18 (53) : 7621 - 7636
  • [48] Mitochondrial death functions of p53
    Marchenko, N. D.
    Moll, U. M.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (02):
  • [49] p53 isoforms gain functions
    Olivares-Illana, V.
    Fahraeus, R.
    ONCOGENE, 2010, 29 (37) : 5113 - 5119
  • [50] Deconstruction of p53 functions and regulation
    Ygal Haupt
    Ana I Robles
    Carol Prives
    Varda Rotter
    Oncogene, 2002, 21 (54) : 8223 - 8231